Aortic hemodynamics in postmenopausal women following cessation of hormone therapy

Ronee E. Harvey, Maja C. Johnson, Sushant M. Ranadive, Michael Joseph Joyner, Brian D. Lahr, Virginia M Miller, Jill N. Barnes

Research output: Contribution to journalArticle

Abstract

Central (aortic) blood pressure and aortic pulse wave characteristics are measures of cardiovascular health, predictive of cardiovascular mortality. Previous studies have compared aortic hemodynamics in women who do and do not take menopausal hormone therapy, but characteristics of these parameters following cessation of treatment have not been defined. Therefore, the purpose of this study was to define aortic pulse wave characteristics in postmenopausal women with and without a history of menopausal hormone therapy use. Pulse wave analysis was conducted on 67 women who had participated in the randomized, double-blind, placebo-controlled Kronos Early Estrogen Prevention Study (KEEPS), 3 years subsequent to the four-year treatment period. Treatment was oral conjugated equine estrogen (0.45 mg/day; n = 18); transdermal 17β-estradiol (50 μg/day; n = 23) each with oral micronized progesterone (Prometrium 200 mg); and placebo pills and patch (n = 26). At post-treat-ment, median age (60 years) and body mass index (27 kg/m2) did not differ across prior treatment assignment. Aortic blood pressures (median systolic 115 mm Hg and diastolic 76 mm Hg) and augmentation index (median 33%) did not differ among women across prior treatment assignment. These results suggest that these doses and formulations of menopausal hormone therapy had no long-term effects on central vascular function 3 years after cessation of treatment.

Original languageEnglish (US)
Article numbere13535
JournalPhysiological Reports
Volume5
Issue number23
DOIs
StatePublished - Dec 1 2017

Fingerprint

Hemodynamics
Hormones
Withholding Treatment
Therapeutics
Pulse
Arterial Pressure
Placebos
Conjugated (USP) Estrogens
Pulse Wave Analysis
Progesterone
Blood Vessels
Estradiol
Estrogens
Body Mass Index
Mortality
Health

Keywords

  • Augmentation index
  • Blood pressure
  • Estrogen

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Aortic hemodynamics in postmenopausal women following cessation of hormone therapy. / Harvey, Ronee E.; Johnson, Maja C.; Ranadive, Sushant M.; Joyner, Michael Joseph; Lahr, Brian D.; Miller, Virginia M; Barnes, Jill N.

In: Physiological Reports, Vol. 5, No. 23, e13535, 01.12.2017.

Research output: Contribution to journalArticle

Harvey, Ronee E. ; Johnson, Maja C. ; Ranadive, Sushant M. ; Joyner, Michael Joseph ; Lahr, Brian D. ; Miller, Virginia M ; Barnes, Jill N. / Aortic hemodynamics in postmenopausal women following cessation of hormone therapy. In: Physiological Reports. 2017 ; Vol. 5, No. 23.
@article{007131c45f4e49b089a2b2f81391dc0b,
title = "Aortic hemodynamics in postmenopausal women following cessation of hormone therapy",
abstract = "Central (aortic) blood pressure and aortic pulse wave characteristics are measures of cardiovascular health, predictive of cardiovascular mortality. Previous studies have compared aortic hemodynamics in women who do and do not take menopausal hormone therapy, but characteristics of these parameters following cessation of treatment have not been defined. Therefore, the purpose of this study was to define aortic pulse wave characteristics in postmenopausal women with and without a history of menopausal hormone therapy use. Pulse wave analysis was conducted on 67 women who had participated in the randomized, double-blind, placebo-controlled Kronos Early Estrogen Prevention Study (KEEPS), 3 years subsequent to the four-year treatment period. Treatment was oral conjugated equine estrogen (0.45 mg/day; n = 18); transdermal 17β-estradiol (50 μg/day; n = 23) each with oral micronized progesterone (Prometrium 200 mg); and placebo pills and patch (n = 26). At post-treat-ment, median age (60 years) and body mass index (27 kg/m2) did not differ across prior treatment assignment. Aortic blood pressures (median systolic 115 mm Hg and diastolic 76 mm Hg) and augmentation index (median 33{\%}) did not differ among women across prior treatment assignment. These results suggest that these doses and formulations of menopausal hormone therapy had no long-term effects on central vascular function 3 years after cessation of treatment.",
keywords = "Augmentation index, Blood pressure, Estrogen",
author = "Harvey, {Ronee E.} and Johnson, {Maja C.} and Ranadive, {Sushant M.} and Joyner, {Michael Joseph} and Lahr, {Brian D.} and Miller, {Virginia M} and Barnes, {Jill N.}",
year = "2017",
month = "12",
day = "1",
doi = "10.14814/phy2.13535",
language = "English (US)",
volume = "5",
journal = "Physiological Reports",
issn = "2051-817X",
publisher = "John Wiley and Sons Inc.",
number = "23",

}

TY - JOUR

T1 - Aortic hemodynamics in postmenopausal women following cessation of hormone therapy

AU - Harvey, Ronee E.

AU - Johnson, Maja C.

AU - Ranadive, Sushant M.

AU - Joyner, Michael Joseph

AU - Lahr, Brian D.

AU - Miller, Virginia M

AU - Barnes, Jill N.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Central (aortic) blood pressure and aortic pulse wave characteristics are measures of cardiovascular health, predictive of cardiovascular mortality. Previous studies have compared aortic hemodynamics in women who do and do not take menopausal hormone therapy, but characteristics of these parameters following cessation of treatment have not been defined. Therefore, the purpose of this study was to define aortic pulse wave characteristics in postmenopausal women with and without a history of menopausal hormone therapy use. Pulse wave analysis was conducted on 67 women who had participated in the randomized, double-blind, placebo-controlled Kronos Early Estrogen Prevention Study (KEEPS), 3 years subsequent to the four-year treatment period. Treatment was oral conjugated equine estrogen (0.45 mg/day; n = 18); transdermal 17β-estradiol (50 μg/day; n = 23) each with oral micronized progesterone (Prometrium 200 mg); and placebo pills and patch (n = 26). At post-treat-ment, median age (60 years) and body mass index (27 kg/m2) did not differ across prior treatment assignment. Aortic blood pressures (median systolic 115 mm Hg and diastolic 76 mm Hg) and augmentation index (median 33%) did not differ among women across prior treatment assignment. These results suggest that these doses and formulations of menopausal hormone therapy had no long-term effects on central vascular function 3 years after cessation of treatment.

AB - Central (aortic) blood pressure and aortic pulse wave characteristics are measures of cardiovascular health, predictive of cardiovascular mortality. Previous studies have compared aortic hemodynamics in women who do and do not take menopausal hormone therapy, but characteristics of these parameters following cessation of treatment have not been defined. Therefore, the purpose of this study was to define aortic pulse wave characteristics in postmenopausal women with and without a history of menopausal hormone therapy use. Pulse wave analysis was conducted on 67 women who had participated in the randomized, double-blind, placebo-controlled Kronos Early Estrogen Prevention Study (KEEPS), 3 years subsequent to the four-year treatment period. Treatment was oral conjugated equine estrogen (0.45 mg/day; n = 18); transdermal 17β-estradiol (50 μg/day; n = 23) each with oral micronized progesterone (Prometrium 200 mg); and placebo pills and patch (n = 26). At post-treat-ment, median age (60 years) and body mass index (27 kg/m2) did not differ across prior treatment assignment. Aortic blood pressures (median systolic 115 mm Hg and diastolic 76 mm Hg) and augmentation index (median 33%) did not differ among women across prior treatment assignment. These results suggest that these doses and formulations of menopausal hormone therapy had no long-term effects on central vascular function 3 years after cessation of treatment.

KW - Augmentation index

KW - Blood pressure

KW - Estrogen

UR - http://www.scopus.com/inward/record.url?scp=85037635194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037635194&partnerID=8YFLogxK

U2 - 10.14814/phy2.13535

DO - 10.14814/phy2.13535

M3 - Article

C2 - 29208690

AN - SCOPUS:85037635194

VL - 5

JO - Physiological Reports

JF - Physiological Reports

SN - 2051-817X

IS - 23

M1 - e13535

ER -